China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency
HAIKOU, China, Oct. 1, 2022 /PRNewswire/ — China Pharma Holdings, Inc. (NYSE American: CPHI; the “Company”) today announced that on September 26, 2022, the Company received notification (the “Deficiency Letter”) from the NYSE AMERICAN LLC (“NYSE American”) informing it that the Company…
Comments Off on China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency